Skip to content
Open access

Impaired Chaperone‐Mediated Autophagy Accelerates Intervertebral Disc Degeneration by Inducing MIDN Accumulation to Target TSC2 for Proteasomal Degradation

Aug 2026 · Advancement of science · 0 citations · 29 references
Medicine

TL;DR

It is demonstrated that CMA activity is downregulated in nucleus pulposus cells from IDD patients and IL‐1β‐induced rat intervertebral disc cell models, causing cytoplasmic accumulation of a novel CMA substrate, Midnolin (MIDN).

Abstract

ABSTRACT Intervertebral disc degeneration (IDD) is a leading cause of low back pain with incompletely understood mechanisms. Although autophagy dysfunction is a documented contributor to IDD, the precise pathobiological role of chaperone‐mediated autophagy (CMA) remains poorly understood. Here, we demonstrate that CMA activity is downregulated in nucleus pulposus cells (NPCs) from IDD patients and IL‐1β‐induced rat intervertebral disc cell models, causing cytoplasmic accumulation of a novel CMA substrate, Midnolin (MIDN). Accumulated MIDN bypasses the ubiquitin‐proteasome system and directly binds to Tuberous Sclerosis Complex 2 (TSC2), mediating its degradation. TSC2 loss relieves mechanistic target of rapamycin complex 1 (mTORC1) inhibition, resulting in mTORC1 hyperactivation, which drives cellular senescence, senescence‐associated secretory phenotype (SASP), and extracellular matrix (ECM) degradation in NPCs. In vitro and in a rat caudal needle puncture model, MIDN knockdown (shRNA), CMA activation (LAMP2A overexpression), or mTORC1 inhibition (Rapamycin) significantly attenuated IL‐1β or MIDN overexpression‐induced senescence and disc degeneration. Our findings reveal an “Impaired CMA–MIDN accumulation–TSC2 degradation–mTORC1 activation” axis central to IDD pathogenesis, offering potential therapeutic targets.

Read PDF

Similar papers

Open access Jul 2026

Inhibition of ETS1/DRP1 axis attenuates intervertebral disc degeneration by suppressing excessive mitochondrial fission.

Findings revealed the ETS1/DRP1 axis as a novel pathogenic mechanism and a potential therapeutic target in IVDD and inhibition of ETS1 via AAV5-mediated RNA interference or targeting DRP1 with CRISPR/dCas9-KRAB system or Mdivi-1 alleviated mitochondrial dysfunction, cellular senescence, ECM degradation, and attenuated...

Peng-Fei Li, Yi-Chen Que, Shuhao Zhang et al. · 0 citations
Jul 2026

The USP5-MATN3 axis in nucleus pulposus cell senescence: A Deubiquitination mechanism protecting against intervertebral disc degeneration.

This study clarifies the molecular mechanism by which the USP5/MATN3 axis regulates cellular senescence and affects IVDD progression, opening up new potential targets for the intervention strategy of IVDD.

Chunyang Fan, Jie-yun Xia, Yao Zhang et al. · 0 citations
Open access Aug 2026

TRIM25 facilitates mitochondrial dysfunction and extracellular matrix degradation by enhancing USP7‐driven ENO1 deubiquitination during intervertebral disc degeneration

Both cellular and animal models confirm that intervention in the TRIM25/USP7/ENO1 axis effectively reverses metabolic imbalance and degenerative progression, offering a promising new therapeutic strategy for IDD.

Xiao-Ming Liu, Wen-Yu Zhang, Hang Feng et al. · 0 citations
Open access Aug 2026

Rapamycin‐nanoliposomes target the mTORC1‐mediated autophagy–lysosomal and NLRP3/Caspase‐1 pathways to inhibit nucleus pulposus cell senescence in intervertebral discs

Collectively, rapa‐lipos target mTORC1‐mediated NCP and ALP to inhibit NP cell senescence, offering a promising strategy for intervertebral disc degeneration prevention.

Hui Xing, Miao Yu, Jia-Bin Liu et al. · 0 citations
Jul 2026

Youthful-state extracellular vesicles for targeted therapy of intervertebral disc degeneration: resolving inflammation and pyroptosis through NF-κB suppression and NLRP1 inactivation

It is demonstrated that youthful-state EVs (Y-EVs) outperform aged donor-derived EVs (O-EVs) in resolving inflammatory cascades within nucleus pulposus (NP) cells and establishes CD55 as a key determinant of their therapeutic superiority.

Zhi-Wei Liao, Kun Wang, M. Lei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.